Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Cancer ; 94: 79-86, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29547834

RESUMO

STUDY AIM: Retrospective studies have demonstrated a worse outcome in breast cancer patients not developing leukopenia during adjuvant chemotherapy. The SBG 2000-1 is the first randomised trial designed to compare individually dosed chemotherapy without G-CSF support based on grade of toxicity to standard-dosed chemotherapy based on body surface area (BSA). METHODS: Patients with early breast cancer were included and received the first cycle of standard FEC (fluorouracil 600 mg/m2, epirubicin 60 mg/m2, cyclophosphamide 600 mg/m2). Patients with nadir leukopenia grade 0-2 after first cycle were randomised between either 6 additional courses of tailored FEC with increased doses (E 75-90 mg/m2, C 900-1200 mg/m2) or fixed treatment with 6 standard FEC. Patients with grade 3-4 leukopenia were registered and treated with 6 standard FEC. Primary end-point was distant disease-free survival (DDFS). RESULTS: The study enrolled 1535 patients, of which 1052 patients were randomised to tailored FEC (N = 524) or standard FEC (N = 528), whereas 401 patients with leukopenia grade 3-4 continued standard FEC and formed the registered cohort. Dose escalation did not statistically significantly improve 10-year DDFS (79% and 77%, HR 0.87, CI 0.67-1.14, P = 0.32) or OS (82% and 78%, respectively, HR 0.89, CI 0.57-1.16, P = 0.38). Corresponding estimates for the registered group of patients were DDFS 79% and OS 82%, respectively. CONCLUSIONS: The SBG 2000-1 study failed to show a statistically significant improvement of escalated and tailored-dosed chemotherapy compared with standard BSA-based chemotherapy in patients with low haematological toxicity, although all efficacy parameters showed a numerical advantage for tailored treatment.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Neoplasias da Mama/tratamento farmacológico , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Neoplasias da Mama/mortalidade , Ciclofosfamida/administração & dosagem , Ciclofosfamida/efeitos adversos , Intervalo Livre de Doença , Esquema de Medicação , Epirubicina/administração & dosagem , Epirubicina/efeitos adversos , Feminino , Fluoruracila/administração & dosagem , Fluoruracila/efeitos adversos , Humanos , Estimativa de Kaplan-Meier , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais
3.
Science ; 164(3883): 1065-7, 1969 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-17796613

RESUMO

The three spin energy levels of divalent nickel impurity ions in sapphire interact strongly with ultrasonic waves whose frequency corresponds to certain allowed transitions between the levels. Under population inversion of the levels it is possible to achieve significant amplification of very high frequency ultrasonic waves by stimulated emission from the spin system.

4.
Science ; 153(3740): 1113-4, 1966 Sep 02.
Artigo em Inglês | MEDLINE | ID: mdl-17737593

RESUMO

Coherent elastic waves were generated and detected at 114,000 megacycles per second in quartz at liquid-helium temperatures. Effective input power was approximately 3 milliwatts. The results suggest that the piezoelectric method may be applicable to similar experiments at much higher frequencies.

5.
Science ; 151(3715): 1179-87, 1966 Mar 11.
Artigo em Inglês | MEDLINE | ID: mdl-17800988
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA